Key result
Laparoscopic colorectal surgery for malignant colon and rectal diseases resulted in an overall survival rate of 90.9% over a median follow-up of 37.5 months.
Why the study?
Laparoscopic surgery is the standard approach for malignant colon and rectal diseases, but surgical and oncological outcomes and survival rates required evaluation at this institution.
What are the clinical and oncological outcomes of laparoscopic colorectal surgery in a single institution over 10 years?
Cohort (n=66)
No
What are the clinical and oncological outcomes of laparoscopic colorectal surgery in a single institution over 10 years?
Laparoscopic colorectal surgery demonstrates good clinical and oncological outcomes with high survival rates in a single-center experience.
Supports single-center laparoscopic colorectal cancer surgery; leaves open multicenter randomized confirmation of oncologic outcomes.
Introduction: The development of laparoscopic colorectal surgery began in 1991. Today, laparoscopic surgery presents standard approach in the surgical treatment of malignant colon and rectal diseases. Aim: Surgical and oncological outcomes and survival rates of laparoscopic colorectal surgery at the Oncology Institute of Vojvodina. Methods: Data were collected prospectively from 66 patients undergoing laparoscopic colorectal surgery between December 2009 and December 2019. Registered data included sex, age, surgical indication and type for the procedure, indication and reason for conversion to open surgery, operative time, performing temporary or permanent stoma, intraoperative bowel perforation, pathologic TNM grade, number of harvested lymph nodes, inclusion of positive resection margin, number of postoperative days at the hospital, postoperative complications, postoperative mortality, presence of distant metastases and survival rates. Results: Laparoscopic procedures were right hemicolectomy in 11/66 (16.7%), left hemicolectomy in 1/66 (1.5%), sigmoid colectomy in 19/66 (28.8%), high anterior rectal resection in 13/66 (19.7%), low anterior rectal resection in 12/66 (18.2%), abdominoperineal amputation of the rectum in 7/66 (10.6%), colectomy in 2/66 (3%) and proctocolectomy in 1/66 (1.5%) patient. The median follow-up was 37.5 months (range 6 to 128). The total number of surviving patients was 60 (90.9%). Conclusion: This study showed that laparoscopic colorectal surgery has good clinical and oncological outcomes.
No takes yet. Share an insight, caveat, or question.
Djermanovic et al. (2020) conducted a cohort in Malignant colon and rectal diseases (n=66). Laparoscopic colorectal surgery was evaluated on Overall survival. Laparoscopic colorectal surgery for malignant colon and rectal diseases resulted in an overall survival rate of 90.9% over a median follow-up of 37.5 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: